These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24475727)

  • 1. [The role of miRNA-155 in cardiovascular diseases].
    Wang X; Du J; Li HH
    Sheng Li Ke Xue Jin Zhan; 2013 Oct; 44(5):377-80. PubMed ID: 24475727
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet miRNAs and cardiovascular diseases.
    Fuentes E; Palomo I; Alarcón M
    Life Sci; 2015 Jul; 133():29-44. PubMed ID: 26003375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
    Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
    Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-143/-145 in Cardiovascular Diseases.
    Zhao W; Zhao SP; Zhao YH
    Biomed Res Int; 2015; 2015():531740. PubMed ID: 26221598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overview and analysis of research projects on miRNA in cardiovascular diseases funded by NSFC].
    Zhu LH; Sun RJ; Dong ED
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):357-62. PubMed ID: 24021116
    [No Abstract]   [Full Text] [Related]  

  • 7. MiRNA Biogenesis and Regulation of Diseases: An Overview.
    Vishnoi A; Rani S
    Methods Mol Biol; 2017; 1509():1-10. PubMed ID: 27826912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA therapeutics in cardiovascular disease models.
    Dangwal S; Thum T
    Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases.
    Gu H; Liu Z; Zhou L
    Biomed Res Int; 2017; 2017():9102909. PubMed ID: 28164128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of microRNAs in the cardiovascular system.
    Scalbert E; Bril A
    Curr Opin Pharmacol; 2008 Apr; 8(2):181-8. PubMed ID: 18243792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA 499 gene expression in patients on hemodialysis with cardiovascular complications.
    El Sharkawy M; Aly O; Elsayed H; Ezzat H; Mohab A; Usama D
    Hemodial Int; 2017 Oct; 21 Suppl 2():S16-S21. PubMed ID: 29064177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
    Calway T; Kim GH
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):131-43. PubMed ID: 25261390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to the series on microRNAs in the cardiovascular system.
    van Rooij E
    Circ Res; 2012 Feb; 110(3):481-2. PubMed ID: 22302754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: role in cardiovascular biology and disease.
    Zhang C
    Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of miR-214 in cardiovascular diseases.
    Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
    Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-based therapeutic approaches in the cardiovascular system.
    Fiedler J; Gupta SK; Thum T
    Cardiovasc Ther; 2012 Feb; 30(1):e9-e15. PubMed ID: 20946325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel techniques and targets in cardiovascular microRNA research.
    Dangwal S; Bang C; Thum T
    Cardiovasc Res; 2012 Mar; 93(4):545-54. PubMed ID: 22072632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial miRNA (MitomiR): a new player in cardiovascular health.
    Srinivasan H; Das S
    Can J Physiol Pharmacol; 2015 Oct; 93(10):855-61. PubMed ID: 26030833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial Commentary: miRNA a tiny genetic tool: Key to the puzzle of cardiovascular disease.
    Giridharan VV; Quevedo J; Krishnamurthy P; Thandavarayan RA
    Trends Cardiovasc Med; 2016 Jul; 26(5):420-2. PubMed ID: 27079892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.